Eva Temkin to Speak at DIA’s Biosimilars Conference

Washington, D.C., Government Matters partner Eva Temkin will speak at the DIA’s Biosimilars Conference on Sept. 20. Eva will co-chair a panel on “Biosimilars Regulatory.” The panel will explore the regulatory considerations that go into deciding whether or not to develop a biosimilar. These include the types of studies that will be necessary to support licensure, the potential for interchangeability designation, the regulatory exclusivity environment, and new regulatory considerations related to the Inflation Reduction Act.